Pfizer Owes $58 Million to Women With Breast Cancer

Breast Cancer awareness is an important part of breast cancer prevention“Wyeth refused to accept responsibility for what it did to these brave women,”  Zoe Littlepage,  a lawyer for Rowatt, Scofield and Forrester, said in an e-mailed statement. “Wyeth can’t hide any more. These women will finally see justice.”

The worlds largest drugmaker, Pfizer, has been denied an appeal by the U.S. Supreme Court for it's drugs Premarin and Provera, both still on the market.   The Nevada Supreme Court  concluded jurors properly held Pfizer’s Wyeth responsible for hiding the breast-cancer risks of Premarin and Prempro in 2007.

Pfizer has been punished for creating an atmosphere of false promises and hiding the evidence that showed significant risks factors for breast cancer for women taking Premarin and Provera.

Annual sales of Wyeth’s Hormone Replacement Therapy for menopause symptoms exceeded $2 billion before a 2002 study, sponsored by the U.S. National Institutes of Health, suggested that women using the medicines had a 24 percent higher risk of breast cancer.

Until 1995, many patients combined Premarin, Wyeth’s estrogen-based drug, with progestin-laden Provera, made by Pfizer’s Pharmacia & Upjohn unit. Wyeth then combined the two hormones in Prempro. The drugs are still on the market.

If you are taking these drugs consider a natural herbal alternative to HRT, Hormone Replacement Therapy that has withstood the test of time.